Delineation of matriptase protein expression by enzymatic gene trapping suggests diverging roles in barrier function, hair formation, and squamous cell carcinogenesis

American Journal of Pathology

Volumn 168, Issue 5, 2006, Pages 1513-1525

  List, Karin ^a   Szabo, Roman ^a   Molinolo, Alfredo ^a   Nielsen, Boye Schnack ^b   Bugge, Thomas H ^a  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^b FINSEN LABORATORY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN 5; KERATIN 5; MATRIPTASE; PROFILAGGRIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CELL ULTRASTRUCTURE; CONTROLLED STUDY; ENZYME SPECIFICITY; EPIDERMIS; FEMALE; GENE ISOLATION; HAIR; HAIR FOLLICLE; HAIR GROWTH; HOMEOSTASIS; IMMUNOHISTOCHEMISTRY; KERATINIZATION; KERATINOCYTE; MALIGNANT TRANSFORMATION; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN CARCINOGENESIS; SQUAMOUS CELL CARCINOMA; THYMOCYTE;

EID: 33646514271     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2006.051071     Document Type: Article

References (49)

1. Fuchs E, Raghavan S: Getting under the skin of epidermal morphogenesis. Nat Rev Genet 2002, 3:199-209
2. Presland RB, Dale BA: Epithelial structural proteins of the skin and oral cavity: function in health and disease. Crit Rev Oral Biol Med 2000, 11:383-408
3. Elias PM, Choi EH: Interactions among stratum corneum defensive functions. Exp Dermatol 2005, 14:719-726
4. Segre J: Complex redundancy to build a simple epidermal permeability barrier. Curr Opin Cell Biol 2003, 15:776-782
5. Candi E, Schmidt R, Melino G: The cornified envelope: a model of cell death in the skin. Nat Rev Mol Cell Biol 2005, 6:328-340
6. Wertz PW, Squier CA: Cellular and molecular basis of barrier function in oral epithelium. Crit Rev Ther Drug Carrier Syst 1991, 8:237-269
7. Laster AJ, Itoh T, Palker TJ, Haynes BF: The human thymic microenvironment: thymic epithelium contains specific keratins associated with early and late stages of epidermal keratinocyte maturation. Differentiation 1986, 31:67-77
8. Hale LP, Markert ML: Corticosteroids regulate epithelial cell differentiation and Hassall body formation in the human thymus. J Immunol 2004, 172:617-624
9. Rogers GE: Hair follicle differentiation and regulation. Int J Dev Biol 2004, 48:163-170
10. Alonso L, Fuchs E: Stem cells of the skin epithelium. Proc Natl Acad Sci USA 2003, 100(Suppl 1):11830-11835
11. Muller-Rover S, Handjiski B, van der Veen C, Eichmuller S, Foitzik K, McKay IA, Stenn KS, Paus R: A comprehensive guide for the accurate classification of murine hair follicles in distinct hair cycle stages. J Invest Dermatol 2001, 117:3-15
12. Kim DR, Sharmin S, Inoue M, Kido H: Cloning and expression of novel mosaic serine proteases with and without a transmembrane domain from human lung. Biochim Biophys Acta 2001, 1518:204-209
13. Lin CY, Anders J, Johnson M, Sang QA, Dickson RB: Molecular cloning of cDNA for matriptase, a matrix-degrading serine protease with trypsin-like activity. J Biol Chem 1999, 274:18231-18236
14. Takeuchi T, Shuman MA, Craik CS: Reverse biochemistry: use of macromolecular protease inhibitors to dissect complex biological processes and identify a membrane-type serine protease in epithelial cancer and normal tissue. Proc Natl Acad Sci USA 1999, 96:11054-11061
15. Tanimoto H, Underwood LJ, Wang Y, Shigemasa K, Parmley TH, O'Brien TJ: Ovarian tumor cells express a transmembrane serine protease: a potential candidate for early diagnosis and therapeutic intervention. Tumour Biol 2001, 22:104-114
16. List K, Haudenschild CC, Szabo R, Chen W, Wahl SM, Swaim W, Engelholm LH, Behrendt N, Bugge TH: Matriptase/MT-SP1 is required for postnatal survival, epidermal barrier function, hair follicle development, and thymic homeostasis. Oncogene 2002, 21:3765-3779
17. List K, Szabo R, Wertz PW, Segre J, Haudenschild CC, Kim SY, Bugge TH: Loss of proteolytically processed filaggrin caused by epidermal deletion of Matriptase/MT-SP1. J Cell Biol 2003, 163:901-910
18. Kang JY, Dolled-Filhart M, Ocal IT, Singh B, Lin CY, Dickson RB, Rimm DL, Camp RL: Tissue microarray analysis of hepatocyte growth factor/Met pathway components reveals a role for Met, matriptase, and hepatocyte growth factor activator inhibitor 1 in the progression of node-negative breast cancer. Cancer Res 2003, 63:1101-1105
19. Oberst M, Anders J, Xie B, Singh B, Ossandon M, Johnson M, Dickson RB, Lin CY: Matriptase and HAI-1 are expressed by normal and malignant epithelial cells in vitro and in vivo. Am J Pathol 2001, 158:1301-1311
20. Suzuki M, Kobayashi H, Kanayama N, Saga Y, Lin CY, Dickson RB, Terao T: Inhibition of tumor invasion by genomic down-regulation of matriptase through suppression of activation of receptor-bound prourokinase. J Biol Chem 2004, 279:14899-14908
21. Hoang CD, D'Cunha J, Kratzke MG, Casmey CE, Frizelle SP, Maddaus MA, Kratzke RA: Gene expression profiling identifies matriptase overexpression in malignant mesothelioma. Chest 2004, 125:1843-1852
22. Riddick AC, Shukla CJ, Pennington CJ, Bass R, Nuttall RK, Hogan A, Sethia KK, Ellis V, Collins AT, Maitland NJ, Ball RY, Edwards DR: Identification of degradome components associated with prostate cancer progression by expression analysis of human prostatic tissues. Br J Cancer 2005, 92:2171-2180
23. Santin AD, Cane S, Bellone S, Bignotti E, Palmieri M, De Las Casas LE, Anfossi S, Roman JJ, O'Brien T, Pecorelli S: The novel serine protease tumor-associated differentially expressed gene-15 (matriptase/MT-SP1) is highly overexpressed in cervical carcinoma. Cancer 2003, 98:1898-1904
24. Bhatt AS, Takeuchi T, Ylstra B, Ginzinger D, Albertson D, Shuman MA, Craik CS: Quantitation of membrane type serine protease 1 (MT-SP1) in transformed and normal cells. Biol Chem 2003, 384:257-266
25. Benaud CM, Oberst M, Dickson RB, Lin CY: Deregulated activation of matriptase in breast cancer cells. Clin Exp Metastasis 2002, 19:639-649
26. Lee JW, Yong Song S, Choi JJ, Lee SJ, Kim BG, Park CS, Lee JH, Lin CY, Dickson RB, Bae DS: Increased expression of matriptase is associated with histopathologic grades of cervical neoplasia. Hum Pathol 2005, 36:626-633
27. Galkin AV, Mullen L, Fox WD, Brown J, Duncan D, Moreno O, Madison EL, Agus DB: CVS-3983, a selective matriptase inhibitor, suppresses the growth of androgen independent prostate tumor xenografts. Prostate 2004, 61:228
28. Santin AD, Zhan F, Bellone S, Palmieri M, Cane S, Bignotti E, Anfossi S, Gokden M, Dunn D, Roman JJ, O'Brien TJ, Tian E, Cannon MJ, Shaughnessy J, Jr., Pecorelli S: Gene expression profiles in primary ovarian serous papillary tumors and normal ovarian epithelium: identification of candidate molecular markers for ovarian cancer diagnosis and therapy. Int J Cancer 2004, 112:14-25
29. List K, Szabo R, Molinolo A, Sriuranpong V, Redeye V, Murdock T, Burke B, Nielsen BS, Gutkind JS, Bugge TH: Deregulated matriptase causes ras-independent multistage carcinogenesis and promotes ras-mediated malignant transformation. Genes Dev 2005, 19:1934-1950
30. Oberst MD, Singh B, Ozdemirli M, Dickson RB, Johnson MD, Lin CY: Characterization of matriptase expression in normal human tissues. J Histochem Cytochem 2003, 51:1017-1025
31. Steinert PM, Marekov LN: The proteins elfin, filaggrin, keratin, keratin intermediate filamens, loricrin, and small proline-rich proteins 1 and 2 are isopeptide cross-linked components of the human epidermal cornified envelope. J Biol Chem 1995, 270:17702-17711
32. Aoyama N, Molin DG, Mentink MM, Koerten HK, De Ruiter MC, Gittenberger-De Groot AC, Poelmann RE: Changing intracellular compartmentalization of beta-galactosidase in the ROSA26 reporter mouse during embryonic development: a light- and electron-microscopic study. Anat Rec A Discov Mol Cell Evol Biol 2004, 279:740-748
33. Hardman MJ, Sisi P, Banbury DN, Byrne C: Patterned acquisition of skin barrier function during development. Development 1998, 125:1541-1552
34. Resing KA, Walsh KA, Dale BA: Identification of two intermediates during processing of profilaggrin to filaggrin in neonatal mouse epidermis. J Cell Biol 1984, 99:1372-1378
35. Simon M, Haftek M, Sebbag M, Montezin M, Girbal-Neuhauser E, Schmitt D, Serre G: Evidence that filaggrin is a component of cornified cell envelopes in human plantar epidermis. Biochem J 1996, 317:173-177
36. Paus R, Muller-Rover S, Van Der Veen C, Maurer M, Eichmuller S, Ling G, Hofmann U, Foitzik K, Mecklenburg L, Handjiski B: A comprehensive guide for the recognition and classification of distinct stages of hair follicle morphogenesis. J Invest Dermatol 1999, 113:523-532
37. Bernot KM, Coulombe PA, McGowan KM: Keratin 16 expression defines a subset of epithelial cells during skin morphogenesis and the hair cycle. J Invest Dermatol 2002, 119:1137-1149
38. Porter RM, Gandhi M, Wilson NJ, Wood P, McLean WH, Lane EB: Functional analysis of keratin components in the mouse hair follicle inner root sheath. Br J Dermatol 2004, 150:195-204
39. Lynch MH, O'Guin WM, Hardy C, Mak L, Sun TT: Acidic and basic hair/nail ("hard") keratins: their colocalization in upper cortical and cuticle cells of the human hair follicle and their relationship to "soft" keratins. J Cell Biol 1986, 103:2593-2606
40. Leyvraz C, Charles RP, Rubera I, Guitard M, Rotman S, Breiden B, Sandhoff K, Hummler E: The epidermal barrier function is dependent on the serine protease CAP1/Prss8. J Cell Biol 2005, 170:487-496
41. Descargues P, Deraison C, Bonnart C, Kreft M, Kishibe M, Ishida-Yamamoto A, Elias P, Barrandon Y, Zambruno G, Sonnenberg A, Hovnanian A: Spink5-deficient mice mimic Netherton syndrome through degradation of desmoglein 1 by epidermal protease hyperactivity. Nat Genet 2005, 37:56-65
42. Yang T, Liang D, Koch PJ, Hohl D, Kheradmand F, Overbeek PA: Epidermal detachment, desmosomal dissociation, and destabilization of corneodesmosin in Spink5-/- mice. Genes Dev 2004, 18:2354-2358
43. Hewett DR, Simons AL, Mangan NE, Jolin HE, Green SM, Fallon PG, McKenzie AN: Lethal, neonatal ichthyosis with increased proteolytic processing of filaggrin in a mouse model of Netherton syndrome. Hum Mol Genet 2005, 14:335-346
44. Lee SL, Dickson RB, Lin CY: Activation of hepatocyte growth factor and urokinase/plasminogen activator by matriptase, an epithelial membrane serine protease. J Biol Chem 2000, 275:36720-36725
45. Lindner G, Menrad A, Gherardi E, Merlino G, Welker P, Handjiski B, Roloff B, Paus R: Involvement of hepatocyte growth factor/scatter factor and met receptor signaling in hair follicle morphogenesis and cycling. FASEB J 2000, 14:319-332
46. Jindo T, Tsuboi R, Imai R, Takamori K, Rubin JS, Ogawa H: The effect of hepatocyte growth factor/scatter factor on human hair follicle growth. J Dermatol Sci 1995, 10:229-232
47. Kyewski B, Derbinski J, Gotter J, Klein L: Promiscuous gene expression and central T-cell tolerance: more than meets the eye. Trends Immunol 2002, 23:364-371
48. Perez-Losada J, Balmain A: Stem-cell hierarchy in skin cancer. Nat Rev Cancer 2003, 3:434-443
49. Owens DM, Watt FM: Contribution of stem cells and differentiated cells to epidermal tumours. Nat Rev Cancer 2003, 3:444-451